Influence of the metal center on hydrolysis of organometallic
anticancer
complexes containing an N-phenyl-2-pyridinecarbothioamide
(PCA) ligand, [M(η6-p-cymene)(N-phenyl-2-pyridinecarbothioamide)Cl]
+
(M = RuII, 1A, and OsII, 2A), as well as their N-fluorophenyl
derivatives [M(η6-p-cymene)(N-fluorophenyl-2-pyridinecarbothioamide)Cl]
+
(M = RuII, 1B, and OsII, 2B) have been investigated using the DFT method in
aqueous medium. The activation energy barriers for the hydrolysis
of 1A (21.5 kcal/mol) and 1B (20.7 kcal/mol)
are found to be significantly lower than those of their corresponding
osmium analogs 2A (28.6 kcal/mol) and 2B (27.5 kcal/mol). DFT evaluated results reveal the inertness of Os(II)–PCA
complex toward the hydrolysis that rationalizes the experimental observations.
However, the incorporation of fluoride substituent slightly decreases
the activation energy for the hydrolysis of Ru(II)– and Os(II)–PCA.
In addition, the interaction of hydrolyzed Ru(II)–PCAs (1AH and 1BH) and Os(II)–PCAs (2AH and 2BH) complexes with the histidine (Hist) have also been investigated. The aquated 1BH and 2BH show an enhanced propensity toward the interaction with
histidine, and their activation Gibbs free energies are calculated
to be 15.9 and 18.9 kcal/mol, respectively. ONIOM (QM/MM) study of
the resulting aquated complexes inside histone protein shows the maximum
stability of the 2BH complex having a binding energy
of −43.6 kcal/mol.